glp-1 microdose Microdosing vs. Standard Dosing: A Provider-Guided Comparison Microdosing GLP-1s: Risks & Considerations
Description
You do not need diabetes to benefit from these peptides
Because GLP-1 therapies improve insulin regulation systemically, they may also enhance signaling pathways in the central nervous system
10.1007/s40279-015-0385-9 [DOI] [PMC free article] [PubMed] [Google Scholar] 47
Youll have continuous access to our care team for questions, dosage adjustments, or progress check-ins at no extra cost
If someone comes in experiencing brain fog, dizziness, weakness, or fatigue, we need to go back to basics, Salkin said
